NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis.

Dawn M. Torres*, Stephen A. Harrison

*Corresponding author for this work

Research output: Contribution to journalComment/debate

31 Scopus citations

Abstract

With expanding waistlines, the prevalence of NAFLD has burgeoned to become the leading cause of chronic liver disease in the USA. A subset of patients with NAFLD meet criteria for NASH with its inherent risk of progression to cirrhosis. Verma et al. addressed the utility of alanine aminotransferase levels for predicting NASH or advanced fibrosis to decide who would benefit from the definitive test of liver biopsy.

Original languageEnglish
Pages (from-to)510-511
Number of pages2
JournalNature Reviews Gastroenterology and Hepatology
Volume10
Issue number9
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis.'. Together they form a unique fingerprint.

Cite this